Zoono Group Valuation

Is ZOON.F undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of ZOON.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate ZOON.F's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate ZOON.F's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for ZOON.F?

Key metric: As ZOON.F is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for ZOON.F. This is calculated by dividing ZOON.F's market cap by their current revenue.
What is ZOON.F's PS Ratio?
PS Ratio	9x
Sales	NZ$1.05m
Market Cap	NZ$9.46m

ZOON.F key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	7.9x
Enterprise Value/EBITDA	-1x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does ZOON.F's PS Ratio compare to its peers?

The above table shows the PS ratio for ZOON.F vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	0.9x
NMGX Nano Magic	3.1x	n/a	US$7.9m
BON Bon Natural Life	0.3x	n/a	US$6.7m
DNMR Danimer Scientific	0.4x	48.2%	US$14.3m
ABLT American Biltrite	0.02x	n/a	US$2.9m
ZOON.F Zoono Group	9x	n/a	US$8.5m

Price-To-Sales vs Peers: ZOON.F is expensive based on its Price-To-Sales Ratio (9x) compared to the peer average (0.9x).

Price to Sales Ratio vs Industry

How does ZOON.F's PS Ratio compare vs other companies in the US Chemicals Industry?

12 Companies	Price / Sales	Estimated Growth	Market Cap
TSE Trinseo	0.04x	5.0%	US$134.17m
ALTO Alto Ingredients	0.1x	3.1%	US$107.31m
CGA Enlightify	0.3x	n/a	US$29.29m
BON Bon Natural Life	0.3x	n/a	US$6.71m

12 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: ZOON.F is expensive based on its Price-To-Sales Ratio (9x) compared to the US Chemicals industry average (1.4x).

Price to Sales Ratio vs Fair Ratio

What is ZOON.F's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ZOON.F PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	9x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate ZOON.F's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Huntsman

US$3.4b

Manufactures and sells diversified organic chemical products worldwide.

HUN

US$19.43

0.4%

-20.1%

Ecora Resources

UK£162.5m

Operates as a natural resource royalty and streaming company in Australia, North and South America, Europe, and internationally.

ECRA.F

UK£0.86

2.0%

-29.5%

Chemtrade Logistics Income Fund

CA$1.4b

Offers industrial chemicals and services in Canada, the United States, and South America.

CGIF.F

CA$8.05

-3.0%

22.0%